Global Vacuum Blood Collection Devices Market (2024-2030)

Market Outlook

The Vacuum Blood Collection Devices market was valued at USD 2,190 million in 2023 and is projected to grow to USD 3,101 million by 2030, with a compound annual growth rate (CAGR) of 5.3% from 2024 to 2030. The manufacturing and distribution of devices used to efficiently and safely gather and preserve blood samples for use in research, therapy, and diagnostics constitute the manufacturing and distribution sectors of the worldwide vacuum blood collection devices market. In hospitals, diagnostic centers, and laboratories, these instruments—which include vacuum-sealed tubes, needles, and holders—are indispensable.

The increased incidence of chronic illnesses like diabetes and cancer, which need frequent blood tests for diagnosis and monitoring, is one of the main factors driving the market's rise. Another factor is the growing number of elderly people, who need more regular medical care and diagnostic procedures. Demand is being further stimulated by technological developments in blood collection equipment, such as safer needles and better tube designs, which make the process safer, simpler, and more precise. The need for blood collection devices is also rising due to the growth of diagnostic laboratories, particularly in emerging economies, and the increased emphasis on preventative healthcare.

There are lots of opportunities in the market, especially in developing nations with growing healthcare infrastructure, like Asia-Pacific and Latin America. Prospects for expansion are presented by advancements in automated and minimally intrusive collection technology. Convenience and financial savings are driving the growth of self-care and home-based diagnostics, which offers manufacturers a chance to create portable, user-friendly products.

Furthermore, these devices' integration of Internet of Things (IoT) technology can improve real-time data collecting and processing, leading to better patient outcomes and easier remote monitoring. The market for vacuum blood collection equipment is poised for robust expansion in the future thanks to these trends.

Key Insights

North America accounted for the largest share of the Vacuum Blood Collection Devices market at 36.41% in 2023. The market for vacuum blood collection devices is dominated in North America by the region's sophisticated healthcare system and high rate of chronic illnesses including diabetes and cardiovascular disease. Regular blood donation campaigns and a strong network of diagnostic centers help the area. The market is dominated by major players like Greiner Bio-One and Becton, Dickinson and Company. With the help of improved healthcare spending, legal frameworks, and technology developments, the United States enjoys a dominant market share. Canada is not far behind, and the market is expanding due in part to a rising need for preventative care and diagnostic testing.

In terms of Product Type, the Blood Collection Tubes accounted for a major share of 69.02%in 2023. By product type, the blood collection tubes segment usually holds a dominant position in the market. This is mainly because blood collection tubes are an integral part of the entire blood collection process, being necessary for the collection and storage of blood samples for a variety of diagnostic procedures.

The increased necessity for routine blood testing, the rise in chronic diseases, the number of diagnostic tests, and the improvements in healthcare infrastructure all contribute to the demand for blood collection tubes. Their market domination is further strengthened by the development of novel blood collection tubes designed for certain uses (such as coagulation, plasma, or serum studies).

Market Dynamics

The increasing incidence of chronic diseases.

The need for healthcare services, such as blood testing, which is essential for diagnosis, monitoring, and treatment, is mostly being driven by the rising prevalence of chronic diseases. Numerous causes, including changing lifestyles, aging populations, and urbanization, are contributing to the rise in chronic diseases such as diabetes, cardiovascular disease, cancer, and respiratory problems.

For instance, millions of people worldwide suffer from diabetes, which necessitates routine blood glucose testing in order to properly manage the illness. Analogously, frequent blood tests are frequently required for cardiovascular illnesses (CVDs), which cause a significant portion of fatalities worldwide. These tests measure triglycerides, cholesterol, and other vital signs that are important for maintaining heart health. Blood tests are routinely administered to cancer patients in order to monitor side effects, track the effectiveness of treatments such as chemotherapy, and identify recurrence.

The aging of the world's population contributes to the rise in chronic ailments since chronic illnesses are more common in older people. It is anticipated that throughout the next several years, the prevalence of chronic illnesses would rise in addition to lifestyle-related risk factors like smoking, poor diet, and sedentary activity.

Healthcare systems are under pressure to deliver prompt and accurate diagnostic services in response. Medical diagnostics still rely heavily on blood tests, and the market for vacuum blood collection equipment has grown as the necessity for routine testing has increased. These instruments are vital for managing the rising burden of chronic diseases, making them vital components of contemporary healthcare. They are renowned for their effectiveness, safety, and capacity to provide high-quality samples.

The development and maintenance of advanced vacuum blood collection devices can be expensive.

A substantial financial commitment is required for the development and upkeep of sophisticated vacuum blood collecting equipment for a number of reasons. The design, testing, and refinement of the devices necessitate significant financing during the research and development (R&D) phase. Prototyping expenses, clinical trial costs, and maintaining strict regulatory compliance are all included in this.

The cost of these products is increased by the use of premium components and cutting-edge technologies. In order to guarantee safety and effectiveness, manufacturers need to invest in advanced production procedures and quality control systems. In order to integrate new technologies and comply with changing regulatory standards, the devices also frequently need to be updated and improved, which raises the cost of maintenance.

In addition, there is fierce competition in the market for these gadgets, so keeping a competitive edge requires constant investment in marketing and sales tactics. Lastly, there is an additional cost layer due to the requirement for comprehensive training and support for healthcare workers. All things considered, these issues add to the high cost of creating and maintaining sophisticated vacuum blood collecting equipment.

Segmental Analysis

Based on Product Type, Vacuum Blood Collection Devices market is segmented into Blood Collection Tubes, Needles and Holders, Blood Collection Sets, Accessories. 

The Blood Collection Tubes section of the Global Vacuum Blood Collection Devices Market is essential for the gathering, storing, and conveyance of blood samples required for diagnostic examinations. These glass or plastic tubes are designed to keep blood in the best possible condition until it is brought to the laboratory. There are several varieties of them, each suitable for a particular type of testing.

Hematology tests, for example, employ EDTA tubes, whereas chemistry tests use Serum Separator Tubes (SSTs) to make it easier to separate serum from blood cells. Citrate tubes are necessary for coagulation research, and heparin tubes, which contain heparin as an anticoagulant, are utilized for plasma testing.

Moreover, the purpose of glucose tubes is to stop glucose metabolism so that glucose levels can be accurately measured. This market is expected to rise as a result of growing demand for diagnostic procedures, an increase in the prevalence of chronic diseases, and technical advancements that improve tube performance.

Advancements include pre-filled and additive-coated tubes, which increase sample accuracy and convenience, also aid in the segment's growth. All things considered, blood collection tubes are an essential part of blood collection systems, guaranteeing accurate sample collection and processing in the field of diagnostics.

Regional Landscape

In the context of regional analysis, the Vacuum Blood Collection Devices market includes North America, Europe, Asia Pacific, South America, and the Middle East and Africa.

The market size of the North America was valued at USD 797.4 million in 2023 and is expected to reach USD 1,079 million by 2030, with a CAGR of 4.6% during the forecast period. The market for vacuum blood collection systems is significant in North America, especially in the US and Canada. The region's supremacy in the industry is largely due to its huge investment in medical technologies and sophisticated healthcare infrastructure. The United States dominates the market due to its high healthcare spending and focus on cutting-edge medical solutions. Canada is a key player as well, with a strong healthcare system and rising modern technology adoption.

The high prevalence of chronic illnesses like diabetes and cardiovascular diseases, which require regular blood tests for diagnosis and monitoring, is one of the main contributing factors. The need for superior vacuum blood collection equipment is further increased by the emphasis on enhancing patient safety and accuracy during medical procedures. The creation of technologies that are more effective, user-friendly, and less intrusive is only one example of how technological improvements are essential to market expansion. Furthermore, the incorporation of electronic health records (EHRs) with blood collection devices improves patient tracking and data management, which is consistent with the region's focus on seamless healthcare delivery.

However, the industry faces difficulties such expensive expenses for cutting-edge technologies and onerous regulations, which can affect the uptake of new products and entry into the market. In addition, the market is very crowded out with well-established competitors, which presents difficulties for newcomers.

All things considered, North America's market is propelled by its advanced healthcare system and an increasing emphasis on cutting-edge medical technology. This region's sustained dominance in the worldwide vacuum blood collection equipment market is guaranteed by its strong emphasis on preventative care and improved diagnostics.

Competitive Landscape

Some of the major companies operating within the Vacuum Blood Collection Devices market are: Poly Medicure Ltd, Becton, Dickinson and Company (BD), InterVac Technology, Terumo BCT, Fresenius Kabi, Weihai Hongyu Medical Devices, Hebei Xinle Sci & Tech, SARSTEDT AG & Co. KG , Greiner Bio-One and Others.   

Recent Developments

In Nov 2020- A new packaging system for its line of blood collection instruments was introduced by Intervactechonlogy OU. For 1, 2, and 5 tube packs, the packaging is offered in paper, plastic, plastic blister, and foil pack.

In June 2018- One of the top manufacturers of medical devices in Italy, Plan 1 Health S.R.L., was purchased by Poly Medicure. The company hopes to expand its portfolio and access new markets in the medical device sector with this acquisition. Furthermore, as per the terms of the agreement, Plan 1 Health S.R. L. shall function as both an incidental subsidiary of Poly Medicure Limited and a direct subsidiary of Poly Medicure B.V.

Table of Contents

FAQ (Frequently Asked Questions)